ENZYME COMMUNICATIONS LTD

10790509
Active Macclesfield

Public relations and communications activities

14 employees website.com
Creative, media and publishing Public relations and communications activitiesOther human health activities
E

ENZYME COMMUNICATIONS LTD

10790509

Public relations and communications activities

Founded 26 May 2017 Active Macclesfield, England 14 employees website.com
Creative, media and publishing Public relations and communications activitiesOther human health activities
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 16 days remaining
Confirmation Submitted 8 Jun 2026 Next due 8 Jun 2027 11 months remaining
Net assets £388K £586K 2024 year on year
Total assets £1M £243K 2024 year on year
Total Liabilities £759K £343K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ENZYME COMMUNICATIONS LTD (10790509), an active creative, media and publishing company based in Macclesfield, England. Incorporated 26 May 2017. Public relations and communications activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2024
Type full
Next accounts 30 Sept 2025
Due by 30 Jun 2026 16 days remaining

Balance Sheet & P&L (2018–2024)

Cash in Bank

£585.62k

Decreased by £110.93k (-16%)

Net Assets

£387.58k

Decreased by £586.03k (-60%)

Total Liabilities

£758.62k

Increased by £343.36k (+83%)

Turnover

£1.46M

Employees

14

Decreased by 1 (-7%)

Debt Ratio

66%

Increased by 36 (+120%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Sept Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 900 Shares £88.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Dec 2018460£460£460
20 Dec 2018440£88.00m£200k

Officers

Officers

1 active 2 resigned
Status
Silver, Gabrielle AlisonDirectorBritishUnited Kingdom5226 Apr 2024Active

Shareholders

Shareholders (1)

Bioscript Limited
100.0%
560

Persons with Significant Control

Persons with Significant Control (4)

4 Active 1 Ceased

Bioscript Limited

United Kingdom

Active
Notified 26 Apr 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Adam Garry Goodband

British

Active
Notified 26 May 2017
Residence United Kingdom
DOB June 1989
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Neil William Kumar

British

Active
Notified 26 May 2017
Residence United Kingdom
DOB July 1989
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
Active
Notified 26 Apr 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Jacqueline Beatrice Wallach

Ceased 8 Feb 2022

Ceased

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom
BIOSCRIPT LIMITED united kingdom
ENZYME COMMUNICATIONS LTD Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jun 2026Persons With Significant ControlChange to Bioscript Limited as a person with significant control on 24 Sept 2024
8 Jun 2026Persons With Significant ControlChange to Bioscript Limited as a person with significant control on 24 Sept 2024
8 Jun 2026Confirmation StatementConfirmation statement made on 25 May 2026 with no updates
13 Aug 2025Confirmation StatementConfirmation statement made on 25 May 2025 with updates
27 Jun 2025AccountsAnnual accounts made up to 30 Sept 2024
8 Jun 2026 Persons With Significant Control

Change to Bioscript Limited as a person with significant control on 24 Sept 2024

8 Jun 2026 Persons With Significant Control

Change to Bioscript Limited as a person with significant control on 24 Sept 2024

8 Jun 2026 Confirmation Statement

Confirmation statement made on 25 May 2026 with no updates

13 Aug 2025 Confirmation Statement

Confirmation statement made on 25 May 2025 with updates

27 Jun 2025 Accounts

Annual accounts made up to 30 Sept 2024

Recent Activity

Latest Activity

Change to Bioscript Limited as a person with significant control on 24 Sept 2024

5 days ago on 8 Jun 2026

Change to Bioscript Limited as a person with significant control on 24 Sept 2024

5 days ago on 8 Jun 2026

Confirmation statement made on 25 May 2026 with no updates

5 days ago on 8 Jun 2026

Confirmation statement made on 25 May 2025 with updates

10 months ago on 13 Aug 2025

Annual accounts made up to 30 Sept 2024

11 months ago on 27 Jun 2025